Published in J Cell Mol Med on January 16, 2015
EGF Receptor Inhibition by Erlotinib Increases Aquaporin 2-Mediated Renal Water Reabsorption. J Am Soc Nephrol (2016) 0.81
Pleiotropic effects of statins: new therapeutic targets in drug design. Naunyn Schmiedebergs Arch Pharmacol (2016) 0.80
The Trafficking of the Water Channel Aquaporin-2 in Renal Principal Cells-a Potential Target for Pharmacological Intervention in Cardiovascular Diseases. Front Pharmacol (2016) 0.78
Effect of Statins on the Nanomechanical Properties of Supported Lipid Bilayers. Biophys J (2016) 0.76
Roflumilast and aquaporin-2 regulation in rat renal inner medullary collecting duct. Physiol Rep (2017) 0.75
A novel AVPR2 gene mutation of X-linked congenital nephrogenic diabetes insipidus in an Asian pedigree. J Int Med Res (2016) 0.75
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet (1994) 40.72
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet (2005) 32.41
Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med (1995) 28.35
Rho, rac, and cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia. Cell (1995) 24.99
Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med (2004) 19.42
Regulation of the mevalonate pathway. Nature (1990) 18.25
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 17.18
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet (2003) 13.69
Rho GTPases and signaling networks. Genes Dev (1997) 11.70
Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA (1997) 10.75
Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. EMBO J (1999) 9.76
Small GTP-binding proteins. Physiol Rev (2001) 9.52
2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 8.90
Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. JAMA (2011) 8.24
Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study) Am J Cardiol (1998) 6.48
Rho GTPases and actin dynamics in membrane protrusions and vesicle trafficking. Trends Cell Biol (2006) 6.33
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). Am J Cardiol (2003) 5.77
Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study. Cardiovasc Drugs Ther (2005) 5.41
Rho GTPases and the control of cell behaviour. Biochem Soc Trans (2005) 5.38
Prostaglandin E receptors. J Biol Chem (2007) 5.29
Aquaporins in the kidney: from molecules to medicine. Physiol Rev (2002) 5.14
Cloning and expression of apical membrane water channel of rat kidney collecting tubule. Nature (1993) 4.99
Vasopressin increases water permeability of kidney collecting duct by inducing translocation of aquaporin-CD water channels to plasma membrane. Proc Natl Acad Sci U S A (1995) 4.35
Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science (1994) 4.27
Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing. J Hepatol (2011) 4.14
HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest (2001) 4.11
Cellular and subcellular immunolocalization of vasopressin-regulated water channel in rat kidney. Proc Natl Acad Sci U S A (1993) 3.82
Aquaporin water channels--from atomic structure to clinical medicine. J Physiol (2002) 3.70
Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol (2001) 3.65
Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci U S A (2001) 3.50
Structural mechanism for statin inhibition of HMG-CoA reductase. Science (2001) 3.45
Simvastatin has anti-inflammatory and antiatherosclerotic activities independent of plasma cholesterol lowering. Arterioscler Thromb Vasc Biol (2001) 3.38
Evolving importance of kidney disease: from subspecialty to global health burden. Lancet (2013) 3.30
Quantitative phosphoproteomics of vasopressin-sensitive renal cells: regulation of aquaporin-2 phosphorylation at two sites. Proc Natl Acad Sci U S A (2006) 3.26
HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA (2000) 3.03
Association of beta-arrestin with G protein-coupled receptors during clathrin-mediated endocytosis dictates the profile of receptor resensitization. J Biol Chem (1999) 3.02
Statins for improving renal outcomes: a meta-analysis. J Am Soc Nephrol (2006) 2.84
Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog. Proc Natl Acad Sci U S A (1981) 2.82
Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants. J Clin Invest (2000) 2.78
Regulation of collecting duct water channel expression by vasopressin in Brattleboro rat. Proc Natl Acad Sci U S A (1994) 2.72
C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation (2001) 2.66
The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study. Nephrol Dial Transplant (2006) 2.50
Statin use and risk of gallstone disease followed by cholecystectomy. JAMA (2009) 2.31
Aquaporin-3 water channel localization and regulation in rat kidney. Am J Physiol (1995) 2.27
Feedback regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in livers of mice treated with mevinolin, a competitive inhibitor of the reductase. J Clin Invest (1980) 2.26
Rho GTPases, statins, and nitric oxide. Circ Res (2005) 2.21
Vasopressin-stimulated increase in phosphorylation at Ser269 potentiates plasma membrane retention of aquaporin-2. J Biol Chem (2008) 2.21
The safety of rosuvastatin as used in common clinical practice: a postmarketing analysis. Circulation (2005) 2.19
Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women. Lancet (2000) 2.17
Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol (2005) 2.14
Desmopressin for nocturnal enuresis in nephrogenic diabetes insipidus. Lancet (2002) 2.10
Combination of secretin and fluvastatin ameliorates the polyuria associated with X-linked nephrogenic diabetes insipidus in mice. Kidney Int (2014) 2.08
Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force. Am J Cardiol (2006) 2.07
Screening for statin-related toxicity: the yield of transaminase and creatine kinase measurements in a primary care setting. Arch Intern Med (2003) 1.98
Distribution of aquaporin-4 water channel expression within rat kidney. Am J Physiol (1995) 1.96
Statin-associated memory loss: analysis of 60 case reports and review of the literature. Pharmacotherapy (2003) 1.93
Lithium nephrotoxicity revisited. Nat Rev Nephrol (2009) 1.92
The ins and outs of aquaporin-2 trafficking. Am J Physiol Renal Physiol (2003) 1.91
Antidiuretic effect of hydrochlorothiazide in lithium-induced nephrogenic diabetes insipidus is associated with upregulation of aquaporin-2, Na-Cl co-transporter, and epithelial sodium channel. J Am Soc Nephrol (2004) 1.86
Association of Rap1a and Rap1b proteins with late endocytic/phagocytic compartments and Rap2a with the Golgi complex. J Cell Sci (1994) 1.78
An assessment of statin safety by hepatologists. Am J Cardiol (2006) 1.78
Regulation of endocytic traffic by rho family GTPases. Trends Cell Biol (2000) 1.77
Aquaporins: water channel proteins of the cell membrane. Prog Histochem Cytochem (2004) 1.75
Effect of pravastatin on loss of renal function in people with moderate chronic renal insufficiency and cardiovascular disease. J Am Soc Nephrol (2003) 1.70
Hypokalemia-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla and cortex. J Clin Invest (1996) 1.64
Lithium-induced downregulation of aquaporin-2 water channel expression in rat kidney medulla. J Clin Invest (1995) 1.63
Current understanding of the cellular biology and molecular structure of the antidiuretic hormone-stimulated water transport pathway. J Clin Invest (1991) 1.60
Effect of simvastatin on renal function in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant (2001) 1.60
Basolateral targeting and microtubule-dependent transcytosis of the aquaporin-2 water channel. Am J Physiol Cell Physiol (2012) 1.60
THE MECHANISM OF ANTIDIURESIS ASSOCIATED WITH THE ADMINISTRATION OF HYDROCHLOROTHIAZIDE TO PATIENTS WITH VASOPRESSIN-RESISTANT DIABETES INSIPIDUS. J Clin Invest (1962) 1.59
Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. J Clin Invest (1997) 1.59
Statin use in COPD patients is associated with a reduction in mortality: a national cohort study. Prim Care Respir J (2012) 1.58
Physiology and pathophysiology of renal aquaporins. J Am Soc Nephrol (1999) 1.58
cAMP-induced morphological changes are counteracted by the activated RhoA small GTPase and the Rho kinase ROKalpha. J Biol Chem (1998) 1.57
Hemodynamic and coagulation responses to 1-desamino[8-D-arginine] vasopressin in patients with congenital nephrogenic diabetes insipidus. N Engl J Med (1988) 1.54
Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project. Circulation (2002) 1.51
Nitric oxide and atrial natriuretic factor stimulate cGMP-dependent membrane insertion of aquaporin 2 in renal epithelial cells. J Clin Invest (2000) 1.50
Inhibition of endocytosis causes phosphorylation (S256)-independent plasma membrane accumulation of AQP2. Am J Physiol Renal Physiol (2003) 1.50
The efficacy and safety of intensive statin therapy: a meta-analysis of randomized trials. CMAJ (2008) 1.48
Inhibitors of HMG-CoA reductase reduce receptor-mediated endocytosis in human kidney proximal tubular cells. J Am Soc Nephrol (2004) 1.48
Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus. Am J Physiol Renal Physiol (2006) 1.48
Mechanisms of the proteinuria induced by Rho GTPases. Kidney Int (2012) 1.48
Clinical review 145: Pleiotropic effects of statins: lipid reduction and beyond. J Clin Endocrinol Metab (2002) 1.47
Membrane recycling and epithelial cell function. Am J Physiol (1989) 1.46
Cloning, characterization, and chromosomal mapping of human aquaporin of collecting duct. J Clin Invest (1994) 1.45
The Rho small G protein family-Rho GDI system as a temporal and spatial determinant for cytoskeletal control. Biochem Biophys Res Commun (1998) 1.44
G protein-coupled prostanoid receptors and the kidney. Annu Rev Physiol (2001) 1.43
Phosphorylation states of Cdc42 and RhoA regulate their interactions with Rho GDP dissociation inhibitor and their extraction from biological membranes. Biochem J (2002) 1.42
Nephrotoxicity of demethylchlortetracycline hydrochloride. A prospective study. Arch Intern Med (1967) 1.41
Benefit-risk assessment of Rosuvastatin 10 to 40 milligrams. Am J Cardiol (2003) 1.41
Inhibitors of 3-hydroxy-3-methylglutaryl-CoA reductase reduce receptor-mediated endocytosis in opossum kidney cells. J Am Soc Nephrol (2004) 1.41
Pravastatin for secondary prevention of cardiovascular events in persons with mild chronic renal insufficiency. Ann Intern Med (2003) 1.39
Cholesterol is required for the formation of regulated and constitutive secretory vesicles from the trans-Golgi network. Traffic (2000) 1.39
Aquaporin-2 localization in clathrin-coated pits: inhibition of endocytosis by dominant-negative dynamin. Am J Physiol Renal Physiol (2002) 1.36
Cholesterol depletion of enterocytes. Effect on the Golgi complex and apical membrane trafficking. J Biol Chem (2000) 1.33
Proteomic analysis of lithium-induced nephrogenic diabetes insipidus: mechanisms for aquaporin 2 down-regulation and cellular proliferation. Proc Natl Acad Sci U S A (2008) 1.33
Water channels encoded by mutant aquaporin-2 genes in nephrogenic diabetes insipidus are impaired in their cellular routing. J Clin Invest (1995) 1.32
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis. Nat Genet (2010) 3.15
Aquaporin-4 orthogonal arrays of particles are the target for neuromyelitis optica autoantibodies. Glia (2009) 1.93
Concomitant, sequential, and hybrid therapy for H. pylori eradication: a pilot study. Clin Res Hepatol Gastroenterol (2013) 1.70
Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis. J Nutr Biochem (2007) 1.62
Ribavirin-induced anemia: mechanisms, risk factors and related targets for future research. Curr Med Chem (2006) 1.60
miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity. EMBO Mol Med (2012) 1.54
Minireview: aquaporin 2 trafficking. Endocrinology (2005) 1.49
Esomeprazole-induced central fever with severe myalgia. Ann Pharmacother (2005) 1.41
Na+/K+-ATPase β1-subunit is recruited in Na-K-2Cl co-transporter isoform 2 multiprotein complexes in rat kidneys: possible role in blood pressure regulation. J Hypertens (2014) 1.40
Nonalcoholic fatty liver disease. Best Pract Res Clin Gastroenterol (2010) 1.35
Coordinate regulation of gallbladder motor function in the gut-liver axis. Hepatology (2008) 1.22
Severe alterations of endothelial and glial cells in the blood-brain barrier of dystrophic mdx mice. Glia (2003) 1.21
cAMP-induced AQP2 translocation is associated with RhoA inhibition through RhoA phosphorylation and interaction with RhoGDI. J Cell Sci (2003) 1.18
Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome. J Nutr (2006) 1.17
Effect of ezetimibe on the prevention and dissolution of cholesterol gallstones. Gastroenterology (2008) 1.16
Aquaporins in skeletal muscle: reassessment of the functional role of aquaporin-4. FASEB J (2004) 1.16
The inner mitochondrial membrane has aquaporin-8 water channels and is highly permeable to water. J Biol Chem (2005) 1.15
Spontaneous cholecysto- and hepatolithiasis in Mdr2-/- mice: a model for low phospholipid-associated cholelithiasis. Hepatology (2004) 1.15
New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation. Biochim Biophys Acta (2009) 1.13
Interacting QTLs for cholesterol gallstones and gallbladder mucin in AKR and SWR strains of mice. Physiol Genomics (2002) 1.11
Altered aquaporin-4 expression in human muscular dystrophies: a common feature? FASEB J (2002) 1.10
Actin remodeling requires ERM function to facilitate AQP2 apical targeting. J Cell Sci (2005) 1.10
Identification of two major conformational aquaporin-4 epitopes for neuromyelitis optica autoantibody binding. J Biol Chem (2011) 1.10
A multidisciplinary evaluation of the effectiveness of cyclosporine a in dystrophic mdx mice. Am J Pathol (2005) 1.10
Significant factors associated with fatal outcome in emergency open surgery for perforated peptic ulcer. World J Gastroenterol (2003) 1.09
Evidences for a leaky scanning mechanism for the synthesis of the shorter M23 protein isoform of aquaporin-4: implication in orthogonal array formation and neuromyelitis optica antibody interaction. J Biol Chem (2009) 1.09
Hypotonicity induces aquaporin-2 internalization and cytosol-to-membrane translocation of ICln in renal cells. Endocrinology (2006) 1.07
Cholesterol absorption is mainly regulated by the jejunal and ileal ATP-binding cassette sterol efflux transporters Abcg5 and Abcg8 in mice. J Lipid Res (2004) 1.07
Activation of TYRO3/AXL tyrosine kinase receptors in thyroid cancer. Cancer Res (2011) 1.07
Silybin combined with phosphatidylcholine and vitamin E in patients with nonalcoholic fatty liver disease: a randomized controlled trial. Free Radic Biol Med (2012) 1.07
Recovery of the soleus muscle after short- and long-term disuse induced by hindlimb unloading: effects on the electrical properties and myosin heavy chain profile. Neurobiol Dis (2005) 1.06
Automated cell-based assay for screening of aquaporin inhibitors. Anal Chem (2009) 1.06
Change of chloride ion channel conductance is an early event of slow-to-fast fibre type transition during unloading-induced muscle disuse. Brain (2002) 1.06
Extracellular calcium antagonizes forskolin-induced aquaporin 2 trafficking in collecting duct cells. Kidney Int (2004) 1.06
Inhibition of aquaporin-4 expression in astrocytes by RNAi determines alteration in cell morphology, growth, and water transport and induces changes in ischemia-related genes. FASEB J (2003) 1.06
Mitochondrial dysfunction in rat with nonalcoholic fatty liver Involvement of complex I, reactive oxygen species and cardiolipin. Biochim Biophys Acta (2007) 1.05
Dietary sphingomyelin suppresses intestinal cholesterol absorption by decreasing thermodynamic activity of cholesterol monomers. Gastroenterology (2002) 1.03
Gentamicin treatment in exercised mdx mice: Identification of dystrophin-sensitive pathways and evaluation of efficacy in work-loaded dystrophic muscle. Neurobiol Dis (2008) 1.03
Role of mitochondria in nonalcoholic fatty liver disease--from origin to propagation. Clin Biochem (2012) 1.03
Characterization of two novel missense mutations in the AQP2 gene causing nephrogenic diabetes insipidus. Nephron Physiol (2006) 1.02
Disuse of rat muscle in vivo reduces protein kinase C activity controlling the sarcolemma chloride conductance. J Physiol (2007) 1.01
Ginsenoside Rb1 reduces fatty liver by activating AMP-activated protein kinase in obese rats. J Lipid Res (2013) 1.01
Gallbladder histopathology during murine gallstone formation: relation to motility and concentrating function. J Lipid Res (2005) 1.00
Role of intestinal sterol transporters Abcg5, Abcg8, and Npc1l1 in cholesterol absorption in mice: gender and age effects. Am J Physiol Gastrointest Liver Physiol (2005) 0.99
Microbiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options. Scand J Gastroenterol (2013) 0.99
Quantifying anomalous intestinal sterol uptake, lymphatic transport, and biliary secretion in Abcg8(-/-) mice. Hepatology (2007) 0.98
Low-calcium diet in hypercalciuric enuretic children restores AQP2 excretion and improves clinical symptoms. Am J Physiol Renal Physiol (2002) 0.97
Molecular pathophysiology and physical chemistry of cholesterol gallstones. Front Biosci (2008) 0.97
Phospholipid transfer protein-deficient mice absorb less cholesterol. Arterioscler Thromb Vasc Biol (2007) 0.97
Dissecting the genetic heterogeneity of gallbladder stone formation. Semin Liver Dis (2011) 0.97
Functional involvement of VAMP/synaptobrevin-2 in cAMP-stimulated aquaporin 2 translocation in renal collecting duct cells. J Cell Sci (2002) 0.97
The Vibrio cholerae cytolysin promotes chloride secretion from intact human intestinal mucosa. PLoS One (2009) 0.96
PNPLA3-associated steatohepatitis: toward a gene-based classification of fatty liver disease. Semin Liver Dis (2013) 0.96
Integrin signaling modulates AQP2 trafficking via Arg-Gly-Asp (RGD) motif. Cell Physiol Biochem (2011) 0.96
Ser-256 phosphorylation dynamics of Aquaporin 2 during maturation from the ER to the vesicular compartment in renal cells. FASEB J (2003) 0.95
Actin cytoskeleton remodeling governs aquaporin-4 localization in astrocytes. Glia (2008) 0.95
New insights into the genetic regulation of intestinal cholesterol absorption. Gastroenterology (2005) 0.95
Aquaporin-4 expression is severely reduced in human sarcoglycanopathies and dysferlinopathies. Cell Cycle (2008) 0.95
Functional involvement of β3-adrenergic receptors in melanoma growth and vascularization. J Mol Med (Berl) (2013) 0.95
Biochemical mechanisms in drug-induced liver injury: certainties and doubts. World J Gastroenterol (2009) 0.95
Lith genes control mucin accumulation, cholesterol crystallization, and gallstone formation in A/J and AKR/J inbred mice. Hepatology (2002) 0.94
Aquaporin-4 autoantibodies in Neuromyelitis Optica: AQP4 isoform-dependent sensitivity and specificity. PLoS One (2013) 0.94
Present and future therapeutic strategies in non-alcoholic fatty liver disease. Expert Opin Ther Targets (2007) 0.94
AQP2 exocytosis in the renal collecting duct -- involvement of SNARE isoforms and the regulatory role of Munc18b. J Cell Sci (2008) 0.94
Intestinal mucosal damage caused by non-steroidal anti-inflammatory drugs: role of bile salts. Clin Biochem (2007) 0.94
Effect of gallbladder hypomotility on cholesterol crystallization and growth in CCK-deficient mice. Biochim Biophys Acta (2009) 0.93
Steatosis in the liver. Compr Physiol (2013) 0.93
Mitochondria in chronic liver disease. Curr Drug Targets (2011) 0.93
Polarized traffic towards the cell surface: how to find the route. Biol Cell (2009) 0.93
The KATP channel is a molecular sensor of atrophy in skeletal muscle. J Physiol (2010) 0.93
Managing nonalcoholic fatty liver disease: recommendations for family physicians. Can Fam Physician (2007) 0.93
Biophysical assessment of aquaporin-9 as principal facilitative pathway in mouse liver import of glucogenetic glycerol. Biol Cell (2012) 0.93
Reduced susceptibility to cholesterol gallstone formation in mice that do not produce apolipoprotein B48 in the intestine. Hepatology (2005) 0.91
Expression of multiple AQP4 pools in the plasma membrane and their association with the dystrophin complex. J Neurochem (2008) 0.91
Dystrophin-dependent and -independent AQP4 pools are expressed in the mouse brain. Glia (2008) 0.91
Overexpression of estrogen receptor alpha increases hepatic cholesterogenesis, leading to biliary hypersecretion in mice. J Lipid Res (2005) 0.91
Functional involvement of Annexin-2 in cAMP induced AQP2 trafficking. Pflugers Arch (2008) 0.90
Long-term functional assessment of antegrade colonic enema for combined incontinence and constipation using a modified Marsh and Kiff technique. Dis Colon Rectum (2007) 0.90
Calcium-sensing receptor and aquaporin 2 interplay in hypercalciuria-associated renal concentrating defect in humans. An in vivo and in vitro study. PLoS One (2012) 0.90
Targets for current pharmacologic therapy in cholesterol gallstone disease. Gastroenterol Clin North Am (2010) 0.90
Ezetimibe: its novel effects on the prevention and the treatment of cholesterol gallstones and nonalcoholic Fatty liver disease. J Lipids (2011) 0.90
MAL/VIP17, a new player in the regulation of NKCC2 in the kidney. Mol Biol Cell (2010) 0.90